Evidence map›Paper›PMID 41669957›Full record

ArticleMovement disorders : official journal of the Movement Disorder Society2026

The Cerebellar Cognitive-Affective Syndrome Scale Reveals Consistent, Early, and Progressive Neuropsychological Deficits in Autosomal-Recessive Spastic Ataxia of Charlevoix-Saguenay: A Large International Cross-Sectional Study.

Julie Fortin, Matthis Synofzik, Élyse-Anne Pedneault-Tremblay, Dominik Hermle, Andreas Thieme, Dagmar Timmann, Roberta La Piana, Bernard Brais, Justine Dolbec, Isabelle Côté and 2 more

Abstract read
In one paragraph

Article in Movement disorders : official journal of the Movement Disorder Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Julie FortinGroupe de Recherche Interdisciplinaire sur les Maladies Neuromusculaires (GRIMN), Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay-Lac-St-Jean, Hôpital de Jonquière, Saguenay, Québec, Canada.ORCID https://orcid.org/0000-0003-1957-8518
Matthis SynofzikDivision Translational Genomics of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research and Center of Neurology, University of Tübingen, Tübingen, Germany.ORCID https://orcid.org/0000-0002-2280-7273
Élyse-Anne Pedneault-TremblayGroupe de Recherche Interdisciplinaire sur les Maladies Neuromusculaires (GRIMN), Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay-Lac-St-Jean, Hôpital de Jonquière, Saguenay, Québec, Canada.ORCID https://orcid.org/0009-0001-4612-9008
Dominik HermleDivision Translational Genomics of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research and Center of Neurology, University of Tübingen, Tübingen, Germany.ORCID https://orcid.org/0009-0006-3266-2203
Andreas ThiemeDepartment of Neurology and Center for Translational Neuro- and Behavioral StudiesSciences (C-TNBS), Essen University Hospital Essen, University of Duisburg-Essen, Essen, Germany.ORCID https://orcid.org/0000-0001-6221-8601
Dagmar TimmannDepartment of Neurology and Center for Translational Neuro- and Behavioral StudiesSciences (C-TNBS), Essen University Hospital Essen, University of Duisburg-Essen, Essen, Germany.ORCID https://orcid.org/0000-0003-1935-416X
Roberta La PianaMontreal Neurological Institute, McGill University, Montreal, Quebec, Canada.ORCID https://orcid.org/0000-0002-4207-5065
Bernard BraisMontreal Neurological Institute, McGill University, Montreal, Quebec, Canada.ORCID https://orcid.org/0000-0003-1394-3561
Justine DolbecGroupe de Recherche Interdisciplinaire sur les Maladies Neuromusculaires (GRIMN), Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay-Lac-St-Jean, Hôpital de Jonquière, Saguenay, Québec, Canada.
Isabelle CôtéGroupe de Recherche Interdisciplinaire sur les Maladies Neuromusculaires (GRIMN), Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay-Lac-St-Jean, Hôpital de Jonquière, Saguenay, Québec, Canada.ORCID https://orcid.org/0000-0002-8360-9086
Cynthia GagnonGroupe de Recherche Interdisciplinaire sur les Maladies Neuromusculaires (GRIMN), Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay-Lac-St-Jean, Hôpital de Jonquière, Saguenay, Québec, Canada.ORCID https://orcid.org/0000-0003-2829-8470
Andreas TraschützDivision Translational Genomics of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research and Center of Neurology, University of Tübingen, Tübingen, Germany.ORCID https://orcid.org/0000-0002-8165-5898

Funding

Clinician Scientist program "PRECISE.net"Consortium international, including the Canadian Institutes of Health Research, Ataxia Charlevoix-Saguenay Foundation and Muscular Dystrophy CanadaEJP RD consortium TREAT-ARCA 01GM2005European Joint Programme on Rare Diseases 825575European Union, project European Rare Disease Research Alliance (ERDERA) 101156595HORIZON-HLTH-2023-DISEASE-07
6 · The paper itself

Abstract

backgroundNeuropsychological deficits have been observed in patients with cerebellar damage, but never thoroughly investigated in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS).

objectivesThe goal is the characterization of presence, severity, and profile of neuropsychological deficits in ARSACS using the cerebellar cognitive-affective syndrome (CCAS) scale.

methodsProspective study including a discovery cohort from Saguenay/Canada (n = 31, median [inter-quartile range] age: 57 [54-62] years), and a validation cohort from Tübingen, Germany (n = 17, 35 [21-43] years) with matched controls (n = 19).

resultsAll ARSACS patients failed in multiple CCAS-related subtests and exceeded cutoffs for "definite CCAS." Even the younger validation cohort failed more subtests than controls (5 [3-7] vs. 1 [1-2], P < 0.001) and had lower CCAS total scores (81 [67-86] vs. 101 [91-106], P < 0.001). Total scores worsened in the older discovery cohort (40 [25-52], P < 0.001) and correlated with age/disease duration (ρ = -0.575, P < 0.001) and ataxia severity (Scale for the Assessment and Rating of Ataxia: ρ = -0.527, P = 0.003).

conclusionsNeuropsychological deficits consistent with CCAS are consistent in ARSACS, present early, and progress in the disease course. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Indexed as

Cerebellar Cognitive Affective SyndromeMuscle SpasticitySpinocerebellar AtaxiasAdultCross-Sectional StudiesDisease ProgressionFemaleHumansMaleMiddle AgedNeuropsychological TestsProspective StudiesSeverity of Illness IndexYoung Adultcerebellar cognitive‐affective syndromecognitionmovement disordersneuropsychologyspastic ataxia of Charlevoix‐Saguenay

Identifiers

PMID41669957
PMCPMC13067325

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.